Literature DB >> 7473477

Interleukin-1 reversibly inhibits the synthesis of biglycan and decorin in intact articular cartilage in culture.

H von den Hoff1, M de Koning, J van Kampen, J van der Korst.   

Abstract

OBJECTIVE: To study the effect of interleukin-1 (IL-1) on the synthesis of proteoglycans biglycan (DSPG-I) and decorin (DSPG-II) in intact bovine articular cartilage.
METHODS: Cartilage bearing sesamoid bones from the metacarpophalangeal joint were cultured with 10 ng/ml IL-1 for 2 days and labelled with [35S] sulfate. One sesamoid bone from each animal had been labelled ex vivo. The remaining 2 were cultured with IL-1 and allowed to recover in control medium before labelling. Control cultures were maintained in medium without IL-1 and labelled concurrently with the experimental series. The dermatan sulfate proteoglycans were purified from 4 M guanidinium chloride extracts of the cartilage by gel filtration on Sepharose CL-2B and CL-4B, on which they appeared as a single peak. Biglycan and decorin were separated by sodium dodecyl sulfide polyacrylamide gel electrophoresis in high salt. Individual lanes from the gel were cut in slices, which were dissolved and counted for radioactivity.
RESULTS: Ex vivo, biglycan accounted for 4% and decorin for 2% of total incorporated sulfate. IL-1 reduced the synthesis of biglycan to 77% of the level of cultured controls and that of decorin to 73%. The synthesis of both proteoglycans returned to the control levels when the IL-1 was removed. IL-1 (10 ng/ml, 2 days) had no significant effect on total proteoglycan synthesis.
CONCLUSION: The inhibition of synthesis of biglycan and decorin by IL-1 might be important in the pathophysiology of cartilage destruction in rheumatic diseases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7473477

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  7 in total

1.  Resistance of small leucine-rich repeat proteoglycans to proteolytic degradation during interleukin-1-stimulated cartilage catabolism.

Authors:  R Sztrolovics; R J White; A R Poole; J S Mort; P J Roughley
Journal:  Biochem J       Date:  1999-05-01       Impact factor: 3.857

2.  Cyclic tensile strain acts as an antagonist of IL-1 beta actions in chondrocytes.

Authors:  Z Xu; M J Buckley; C H Evans; S Agarwal
Journal:  J Immunol       Date:  2000-07-01       Impact factor: 5.422

3.  Asporin expression is highly regulated in human chondrocytes.

Authors:  Elise Duval; Nicolas Bigot; Magalie Hervieu; Ikuyo Kou; Sylvain Leclercq; Philippe Galéra; Karim Boumediene; Catherine Baugé
Journal:  Mol Med       Date:  2011-04-25       Impact factor: 6.354

4.  Dual biological functions of an interleukin-1 receptor antagonist-interleukin-10 fusion protein and its suppressive effects on joint inflammation.

Authors:  Deh-Ming Chang; Song-Kun Shyue; Shao-Hsiang Liu; Yen-Teen Chen; Chiou-Yueh Yeh; Jenn-Huang Lai; Herng-Sheng Lee; Ann Chen
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

Review 5.  [Rheumatoid arthritis: new molecular and cellular aspects].

Authors:  O Distler; U Müller-Ladner; J Schölmerich; R E Gay; S Gay
Journal:  Med Klin (Munich)       Date:  1999-12-15

Review 6.  New therapeutic targets for rheumatoid arthritis.

Authors:  H J Dinant; B A Dijkmans
Journal:  Pharm World Sci       Date:  1999-04

Review 7.  Macrophages in rheumatoid arthritis.

Authors:  R W Kinne; R Bräuer; B Stuhlmüller; E Palombo-Kinne; G R Burmester
Journal:  Arthritis Res       Date:  2000-04-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.